Introducing IdaFloTR
A wireless wrist bracelet, setting a new standard for transradial access compression management
Continuous real-time
Offers continuous real-time monitoring of radial artery patency maintaining artery health for future interventions
Early Alerts
Provides early alerts for potential occlusion, ensuring procedural safety and post-op artery patency
Continuous Monitoring
Precise pressure management ensures bleeding control with continued flow, reducing nurse workload
Need
more details?
We are here to assist. Contact us by phone, e-mail or via our social media channels.
Our Address:
IDAHealth Inc.
Van Siburgstraat 34, 3863 HW - Nijkerk
The Netherlands
Call us:
+1 9548062962
About Us
IDAHealth Inc. is a U.S. C-Corporation headquartered in The Netherlands. We’re backed by a robust global patent portfolio and a clear long-term strategic vision. We’re committed to uncompromising quality and clinical efficacy as we continue to expand the potential of our sensor technologies across a range of medical applications.
Two Clinical Benefits -
One Mechanism
Clinical Benefits for Patients
-
Continuous flow monitoring enables early detection of compromised radial artery patency during the compression window
-
Enhances both patient safety and procedural efficiency
-
Improves patient outcomes by preserving radial artery future use
Clinical Workflow Integration
-
Patient-tailored compression ensures adequate hemostasis while maintaining blood flow
-
Predictive algorithm allows nurses to make adjustments and intervene before a problem occurs
-
Eliminates blind spots in patient monitoring & streamlines workflow
What our Clients Say
“IdaFlo TR promises to set the Guided Hemostasis standard for post transradial procedure compression protocols giving us the tool to achieve patent hemostasis for every patient”
— Giovanni Amoroso, MD, PhD Interventional Cardiologist, OLVG Hospital Amsterdam, The Netherlands
What our Clients Say
We are interested in evaluating this technology in hopes of integrating this potentially valuable monitoring tool into our standard protocols for managing radial artery catheterization procedures”
— Dr. Jim Nolan, Interventional Cardiologist,
Leeds Hospital, UK
What our Clients Say
IdaFlo TR is a significant advancement in radial artery management. Real-time blood flow monitoring has the potential to reduce RAO rates, streamline protocols, and improve outcomes. I’m excited for its clinical trials and the opportunity to transform transradial care.”
— Prof. Stephane Carlier, Interventional Cardiologist, University of Mons (UMONS) Mons, Belgium